Researchers have used a personalised base-editing gene therapy to successfully treat an infant with carbamoyl-phosphate ...

Researchers at the Max Planck Institute for Evolutionary Anthropology have addressed a longstanding challenge in CRISPR ...

Scientists have developed SMART (silently mutate and repair template), a strategy that dramatically expands the editable ...

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 gene-editing tool to spiders. Following the genetic modification, the spiders ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

CRISPR Therapeutics AG (CRSP) is a biotech firm pioneering gene-editing therapies leveraging its proprietary CRISPR/Cas9 platform. CRSP’s approved product is Casgevy, for the treatment of sickle ...

Now, a first-in-human clinical trial is testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal cancers. The results show encouraging signs of safety ...

The 2012 landmark Science paper demonstrating the use of CRISPR-Cas9 as a gene-editing tool catapulted gene-editing technologies to new levels. Yet, that breakthrough also highlighted precision ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas ... Although Cas12f proteins benefit from compact size for delivery, their gene-editing activity remains limited. By adding an N-terminal α ...

Gene editing, once a theoretical ambition, has matured into a revolutionary frontier in biotechnology. Technologies like CRISPR-Cas9, TALENs, and Zinc Finger Nucleases (ZFNs) have unlocked ...